Omeprazole Impurity F
|
奧美拉唑雜質(zhì)F
|
125656-82-8
|
Benzyl tosyllyl glycinate
|
甲苯磺酰基甘氨酸芐酯
|
63366-76-7
|
(2,3-Dichloro-6-Nitrophenyl)Methanamine
|
(2,3-二氯-6-硝基苯基)甲胺
|
70380-49-3
|
Diethyl 2,2'-((6-amino-2,3-dichlorophenyl)azanediyl)diacetate
|
二乙基 2,2'-((6-氨基-2,3-二氯苯甲基)氮烷二基)二乙酸酯
|
183620-20-4
|
Ethyl (6-amino-2,3-dichlorobenzyl)glycinate
|
N-(6-氨基-2,3-二氯苯)甘氨酸乙酯
|
85325-12-8
|
Ethyl 5,6-dichloro-3,4-dihydro-2(1H)-iminoquinazoline-3-acetate hydrobromide
|
(乙基 2-(5,6-二氯-2-亞氨基-1,4-二氫喹唑啉-3(2H)-基)乙酸酯氫溴酸鹽)
|
70381-75-8
|
Ethyl N-(2.3-dichloro-6-nitrobenzyl)glycine
|
N-(2,3-二氯-6-硝基苯)甘氨酸乙酯鹽酸鹽
|
70380-50-6
|
2,3,4-Trichloronitrobenzene
|
2,3,4-三氯硝基苯
|
17700-09-3
|
1,2,3-Trichloro-4,6-dinitrobenzene
|
1,2,3-三氯-4,-6-二硝基苯
|
6379-46-0
|
2,3-Dichloro-6-nitrobenzonitrile
|
2,3-二氯-6-硝基苯腈
|
2112-22-3
|
Sivelestat
|
西維來司他
|
127373-66-4
|
Budesonide((r)-budesonlde)
|
布地奈德((r)-budesonlde)
|
51372-29-3
|
Cacharon
|
卡沙侖
|
2037-95-8
|
2-[[4-(2,2-dimethyl-1-oxopropoxy)phenyl]sulfonyl]amino1-benzoic acid
|
2-[[4-(2,2-二甲基-1-氧代丙氧基)苯基]磺酰基]氨基1-苯甲酸
|
188114-98-9
|
Methyl 3-Methylquinoline-2-carboxylate
|
3-甲基喹啉-2-甲酸甲酯
|
53821-46-8
|
AZD9291 Intermediate 3
|
AZD9291中間體3
|
1421372-67-9
|
5,6,7,8-Tetrahydroquinoline
|
5,6,7,8-四氫喹啉對照品
|
10500-57-9
|
4-(4-Oxobutyl)benzoic acid methyl ester
|
4-(4-氧代丁基)苯甲酸甲酯
|
106200-41-3
|
2-((4-hydroxyphenyl)sulfonamide)benzoic acid
|
2-((4-羥基苯基)磺酰胺)苯甲酸
|
1655497-02-1
|
6-Amino-2,3-dichlorobenzonitrile
|
6-氨基-2,3-二氯苯甲腈
|
147249-41-0
|
6,7-Dichloro-5,10-dihydroimidazo[2,1-b]quinazolin-2(3H)-one
|
6,7-二氯-3,5-二氫咪唑并[2,1-b]喹唑啉-2(1H)-酮(INF)
|
68475-42-3
|
1,2,3-Trichloro-5-nitrobenzene
|
1,2,3-三氯-5-硝基苯
|
20098-48-0
|
(6-amino-2,3,4-trichlorobenzene)ethyl glycinate
|
(6-氨基-2,3,4-三氯苯)甘氨酸乙酯
|
2187431-31-6
|
Trichlorine impurities
|
三氯雜質(zhì)
|
1092352-99-2
|
4,5-Dichloro-1H-indazole
|
4,5-二氯-1H-吲唑
|
1020243-02-0
|
Ring-opening impurity methyl ester
|
開環(huán)雜質(zhì)甲酯
|
752151-24-9
|
2-Amino-5,6-dichloro-3(4H)-quinazoline Acetic Acid
|
2-(2-氨基-5,6-二氯喹唑啉-3(4H)-基)乙酸
|
1159977-03-3
|
Nintedanib impurity 1
|
尼達尼布雜質(zhì)2
|
|
Bupropion Impurity
|
安非他酮雜質(zhì)
|
1049718-57-1
|
Isaconazole sulfate impurity BAL31264
|
硫酸艾沙康唑雜質(zhì)BAL31264
|
|
Ibrutinib Impurity C (Ibrutinib Crude Impurity Serial No. 3)
|
伊布替尼雜質(zhì)C(伊布替尼粗品雜質(zhì)序號3)
|
|
Ticagrelor impurity TK-02
|
替格瑞洛雜質(zhì)TK-02
|
|
Ticagrelor impurity TK-P
|
替格瑞洛雜質(zhì)TK-P
|
|
1H-pyrazol-4-ylmethylamine
|
4-(氨基甲基)吡唑
|
37599-59-0
|
Quinazoline, 7-bromo-4-chloro-8-methyl-
|
7-溴-4-氯-8-甲基喹唑啉
|
1592956-60-9
|
5-[(Methylamino)methyl]-2-furanmethanol
|
5-甲氨基-甲基-呋喃甲醇
|
66357-60-6
|
6-Quinazolinecarboxaldehyde, 3,4-dihydro-2-methyl-4-oxo-
|
3,4-二氫-2-甲基-4-氧代-6-喹唑啉甲醛
|
1802925-55-8
|
(4-Fluoro-3-methoxy-phenyl)-methyl-amine
|
4-氟-3-甲氧基-N-甲基苯胺
|
904321-01-3
|
6-(Trifluoromethyl)benzo[b]thiophen-3-amine
|
6-(TRIFLUOROMETHYL)BENZO[B]THIOPHEN-3-AMINE
|
165108-01-0
|
tert-Butyl 6-forMylpyridin-3-ylcarbaMate
|
(6-甲?;拎?3-基)氨基甲酸叔丁酯
|
1196156-55-4
|
3-METHYLQUINOLINE-2-CARBOXYLIC ACID
|
-甲基喹啉-2-羧酸
|
92513-28-5
|
6-Amino-3-cyano-2-fluoropyridine
|
6-氨基-3-氰基-2氟吡啶
|
1445962-29-7
|
1H-Pyrazolo[3,4-b]pyridine-3-Methanol
|
(2H-吡唑并[3,4-b]吡啶-3-基)甲醇
|
1211589-17-1
|
Benzoic acid, 4-bromo-2-(methylamino)-, methyl ester
|
4-溴-2-(甲基氨基)苯甲酸甲酯
|
1367708-38-0
|
2-CYANO-3-METHYLQUINOLINE
|
3-甲基-2-氰基喹啉
|
19051-05-9
|
Sodium 4-hydroxy-1,3-benzodisulfonate
|
4-羥基-1,3-苯二磺酸鈉
|
99-77-5
|
4-(Chlorosulfonyl)phenyl pivalate
|
對新戊酰氧基苯磺酰氯
|
150374-99-5
|
(2-((4-hydroxyphenyl)sulfonamido)benzoyl)glycine
|
(2-((4-羥基苯基)磺酰胺基)苯甲?;?甘氨酸
|
155023-59-9
|
EP-A
|
廿碳五烯酸
|
25378-27-2
|
4-(4-Cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-33-carboxylamide
|
4-(4-氰基-2-甲氧基苯基)-5-乙氧基-2,8-二甲基-1,4-二氫-1,6-萘啶-33-羧酸酰胺
|
|
Levofloxacin nitrosamines
|
左氧氟沙星亞硝胺
|
|
Cefuroxime sodium Impurity 67
|
頭孢呋辛雜質(zhì)
|
1177709-12-4
|
Fosfomycin Diastereomer 1
|
磷霉素非對映異構(gòu)體雜質(zhì)
|
27357-50-2
|
Phosphonic acid, [(2S,3S)-3-methyloxiranyl]- (9CI)
|
磷霉素非對映異構(gòu)體雜質(zhì)
|
438210-39-0
|
Phosphonic acid, 1,2-propadienyl-, diethyl ester
|
磷霉素基因毒雜質(zhì)A
|
1609-72-9
|
Gadolinium cloth alcohol intermediate II impurity 4
|
釓布醇中間體II雜質(zhì)4
|
|
Tofacitinib Impurity 145
|
托法替尼雜質(zhì)145
|
|
Ranosine impurity 6
|
雷諾嗪雜質(zhì)6
|
162712-35-8
|
EP-A
|
EP-A
|
99-65-0
|
D-Hor
|
D-氫化乳清酸
|
5988-53-4
|
Landinolol hydrochloride control/A001-M3Z3
|
鹽酸蘭地洛爾對照品/A001-M3Z3
|
|
Urea, N-[3-(1-methylethyl)-1-phenyl-1H-pyrazol-5-yl]-N'-(3-methylphenyl)-
|
1-(3-異丙基-1-苯基-1H-吡唑-5-基)-3-(間甲苯基)脲
|
1448705-21-2
|
2-Propanamine, 2-methyl-1-phenoxy-
|
2-甲基-1-苯氧基丙烷-2-胺
|
61040-67-3
|
α-Thio-4-[2-(5-ethyl-2-pyridinyl)ethoxy]benzenepropanoic Acid Disulfide
|
吡格列酮雜質(zhì)
|
1229114-67-3
|
a-[(Aminocarbonyl)thio]-4-[2-(5-ethyl-2-pyridinyl)ethoxy]benzenepropanoic Acid Ethyl Ester
|
吡格列酮雜質(zhì)
|
868754-41-0
|
9H-Pyrido[3,4-b]indole-9-butanamide, 7-methoxy-1-methyl-
|
|
2377234-80-3
|
Pyrazolo[1,5-a]pyridine, 5-chloro-7-methyl-
|
5-氯-7-甲基吡唑并[1,5-a]吡啶
|
1427374-70-6
|
Thieno[3,2-b]pyridine-6-carboxylic acid, 4,5-dihydro-7-hydroxy-5-oxo-, ethyl ester
|
THIENO[3,2-B]PYRIDINE-6-CARBOXYLIC ACID, 4,5-DIHYDRO-7-HYDROXY-5-OXO-, ETHYL ESTER
|
74695-36-6
|
4,7,10,13,16,19-Docosahexaenoic acid, 2,3-dihydroxypropyl ester, (4Z,7Z,10Z,13Z,16Z,19Z)-
|
(4Z,7Z,10Z,13Z,16Z,19Z)-2,3-二羥基丙基二十二碳烯酸-4,7,10,13,16,19-己酯
|
140670-40-2
|
DIDOCOSAHEXAENOIN
|
:二十二碳六烯酸甘油二酯
|
124538-05-2
|
QJH-2
|
QJH-2
|
|
QJH-1
|
QJH-1
|
|
S-flurbiprofen menthol ester
|
S-氟比洛芬薄荷醇酯
|
|
4-((6,7-dimethoxyisoquinoline-1-yl)methyl)benzene 1,2-diol hydrochloride
|
4-((6,7-二甲氧基異喹啉-1-基)甲基)苯1,2-二醇鹽酸鹽
|
|
Cefazoloxime decarboxylic acid (parent nucleus position 2) impurity
|
頭孢唑肟脫羧酸(母核 2 號位)雜質(zhì)
|
|
Cefazoloxime sodium double lateral chain 1
|
頭孢唑肟鈉雙側(cè)鏈1
|
|
Gadolinium cloth alcohol intermediate II impurity 7
|
釓布醇中間體II雜質(zhì)7
|
|
Gadolinium cloth alcohol intermediate II impurity 6
|
釓布醇中間體II雜質(zhì)6
|
|
Gadolinium cloth alcohol intermediate II impurity 2
|
釓布醇中間體II雜質(zhì)2
|
|
Gadolinium cloth alcohol intermediate II impurity 1
|
釓布醇中間體II雜質(zhì)1
|
|
Cephalexin impurity G
|
頭孢氨芐雜質(zhì)G
|
|
Gadolinium cloth alcohol intermediate II impurity 3
|
釓布醇中間體II雜質(zhì)3
|
|
Gadolinium cloth alcohol intermediate II impurity 5
|
釓布醇中間體II雜質(zhì)5
|
|
ALM-1
|
N-[4-2-(甲酰氨基乙?;?-5-甲氧基-2-苯氧基苯基)]-甲磺酰胺
|
149456-98-4
|
Cinepazide Impurity 5
|
桂哌齊特雜質(zhì)5
|
1078-64-4
|
Nintedanib impurity 1
|
尼達尼布雜質(zhì)1
|
334951-61-0
|
Budesonide intermediate II. Impurity C
|
布地奈德中間體Ⅱ雜質(zhì)C
|
52-21-1
|
TRIDOCOSAHEXAENOIN
|
二十二碳六烯酸三甘油酯對照品
|
11094-59-0
|
Caspofungin impurity E
|
卡泊芬凈雜質(zhì)E
|
|
Caspofungin IMpurity A
|
卡泊芬凈雜質(zhì)A
|
1202167-57-4
|
Caspofungin Impurity B
|
卡泊芬凈雜質(zhì)B
|
|
Caspofungin Impurity D
|
卡泊芬凈雜質(zhì)D
|
|
SNAC Impurity 01
|
SNAC雜質(zhì)01
|
486-58-8
|
ALM-1-3
|
ALM-1-3
|
|
5-ethynyl-6-fluoropyridin-2-amine
|
5-乙炔基-6-氟吡啶-2-胺
|
1824299-95-7
|
(1R,2S)-2-[[(2,4-Dimethyl-5-pyrimidinyl)oxy]methyl]-2-(3-fluorophenyl)-N-2-pyridinylcyclopropanecarboxamide
|
萊伯雷生雜質(zhì)4
|
1369763-94-9
|
(-)-Diltiazem
|
(-)-地爾硫卓
|
75472-92-3
|
fosfomycin
|
磷霉素非對映異構(gòu)體雜質(zhì)
|
45629-00-3
|
N,N-dimethyl-a-[2-(2-naphthoxy)ethyl]benzamine hydrochloride (dapoxetine hydrochloride impurity) R isomer
|
N,N-二甲基-a-[2-(2-萘氧基)乙基]苯甲胺鹽酸鹽(鹽酸達泊西汀雜質(zhì))R異構(gòu)體
|
|
2,3-Dichloro-6-nitrophenol
|
2,3-二氯-6-硝基苯酚
|
28165-60-8
|